• Home/
  • Blog/
  • FINAL SPEAKERS FOR BIONANO GENOMICS 2022 VIRTUAL SYMPOSIUM

Bionano Genomics is excited to share the exceptional speaker line up for its 2022 Symposium, beginning this Monday, January 10. This year’s four-day event will feature 31 oral presentations from 27 different speakers from prominent institutions across North America and Europe.

Register today to join us as leading researchers share their latest discoveries in optical genome mapping in constitutional cytogenomics, hematologic malignancies, solid tumors and in combination with next-generation sequencing (NGS). All are welcome; registration is free.

The virtual event runs next week, Monday, January 10 through Thursday, January 13, 2022. Each day will feature speaker presentations, a live panel with Q&A and a scientific poster exhibit within the virtual exhibition hall.

Full speaker line up:

Monday, January 10: Constitutional Cytogenomics

Speaker Name Institution State / Country Talk Title
Chaim Jalas The Foundation for Embryonic Competence New Jersey, USA Validation of Optical Genome Mapping for Preimplantation Genetic Analysis – Structural Rearrangement (PGD-SR) Applications
Dr. Laila El-Khattabi Assistance Publique–Hôpitaux de Paris (AP-HP) – Université de Paris Paris, France Balanced Translocations Associated with Male Infertility: How Optical Genome Mapping Could Lead to New Discoveries?
Dr. Shirley Heggarty Belfast Health and Social Care Trust Belfast, UK Clinical Utility of Optical Genome Mapping in a Constitutional Cytogenetics Laboratory
Dr. Alexander Hoischen Radboud University Medical Center Nijmegen, Netherlands Optical Genome Mapping: Mapping Difficult Structural Variant Types – Repeat Expansions
Dr. Anwar Iqbal University of Rochester Medical Center New York, USA Validation Study of Optical Genome Mapping for Postnatal and Prenatal Clinical Research According to Established NYSDOH Guidelines
Dr. Nikhil Sahajpal Augusta University Georgia, USA Enhanced Structural Variation Detection with OGM in Constitutional Disorders

Tuesday, January 11: Hematologic Malignancies

Speaker Name Institution State / Country Talk Title
Bence Dvorak University Children’s Hospital Zurich- Eleonore Foundation Zurich, Switzerland Characterization of Plasma Cell Dyscrasias (PCD) by Optical Genome Mapping
Dr. Jonathan L. Lühmann Hannover Medical School Hannover, Germany The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia
Dr. Anna Puiggros Hospital del Mar Barcelona, Spain The Hidden Side of Genomic Complexity: Learning from OGM in Chronic Lymphocytic Leukemia
Dr. Barbara Dewaele University Hospitals Leuven Leuven, Belgium Opportunities of Optical Genome Mapping for Genetic Diagnosis in Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia
Dr. Kornelia Neveling Radboud University Medical Center Nijmegen, Netherlands Technical and Clinical Validation of Optical Genome Mapping
Dr. Elena García Sánchez Hospital Infantil Universitario Niño Jesús Madrid, Spain Optical Genome Mapping for Diagnosis of Paediatric Leukaemia
Dr. Brynn Levy Columbia University Medical Center New York, USA Assessing Genomic Aberrations in AML using Optical Genome Mapping: Insights from a National Multi-Center Study
Dr. Adrian Dubuc Harvard Medical School Brigham and Women’s Hospital Massachusetts, USA Shining a New Light on Cancer Cytogenetics: Leveraging Novel Technological Approaches for Improved Understanding in B-ALL
Dr. Adam C. Smith Laboratory Medicine Program, University Health Network, University of Toronto Toronto, Canada A Year in Review: Parallel Testing of Hematologic Malignancies Using Optical Genome Mapping Compared to Conventional Cytogenetics
Dr. Saurabh Gupta Quest Diagnostics New Jersey, USA Optical genome mapping: Utility for stratification of B-CLL by accurate identification of clinically relevant structural variants

Wednesday, January 12: Solid Tumors

Speaker Name Institution Talk Title
Dr. Elena García Sánchez Hospital Infantil Universitario Niño Jesús Madrid, Spain Optical Genome Mapping: Application for Analysis of Non-Haematological Cancers
Dr. Tuomo Mantere University of Oulu, Finland Oulu, Finland Optical Genome Mapping in Unexplained High-Risk Breast Cancer Families
Dr. Gopalrao Velagaleti UT Health – San Antonio Texas, USA Vigor and Reproducibility in Research: The Cell Line Saga: Is OGM the Answer?
Dr. Matthew Brian Couger Brigham and Women’s Hospital Massachusetts, USA The Chromosomal Landscape of Mesothelioma
Dr. Juan Diaz Martin Instituto de Biomedicina de Sevilla (IBiS) Sevilla, Spain Complex Rearrangement Patterns in Undifferentiated Small Round Cell Sarcomas Associated with Poor Outcomes in Clinical Research
Dr. Ravindra Kolhe Medical College of Georgia at Augusta University Georgia, USA Utility of Optical Genome Mapping for the Chromosomal Characterization of Solid Tumors

Thursday, January 13: OGM + NGS

Speaker Name Institution Talk Title
Dr. Kornelia Neveling Radboud University Medical Center Nijmegen, Netherlands Optical Genome Mapping: Different Types of Hidden SV’s in Families with Inherited Retinal Diseases
Dr. Mariangela Sabatella Princess Máxima Center for Pediatric Oncology Utrecht, Netherlands Enlightening the Dark Matter of the Genome: OGM Identifies a Germline Retrotransposon Insertion in SMARCB1 in Two Siblings with Atypical Teratoid Rhabdoid Tumors
Dr. Gordana Raca Children’s Hospital Los Angeles California, USA OGM and Capture-Based RNA-Seq Enable Comprehensive Genomic Characterization of Pediatric B-lymphoblastic Leukemias
Arran Constantine bit.bio Cambridge, UK Cytogenetic QC at bit.bio: How a Next-Generation Cytogenetics Platform Enhances Quality Control of Next-Generation Cells
Dr. Saumyaa Saumyaa AstraZeneca Cambridge, UK Detection and Characterization of On- and Off-target Integration of Foreign DNA in the Host Genomes, for Therapeutic Cell and Gene Therapy Development, Using OGM
Dr. Laila El-Khattabi Assistance Publique–Hôpitaux de Paris (AP-HP) – Université de Paris Paris, France Molecular Characterization of Genome Structural Variants in Developmental Disorders: Comparison Between OGM and Short Read WGS
Dr. Jens Luebeck University of California, San Diego California, USA Combined NGS and OGM Reveal the Complex Structures of Circular Extrachromosomal DNA and other Focal Amplifications in Cancer Genomes
Dr. Ravindra Kolhe Medical College of Georgia at Augusta University Georgia, USA Clinical Utility of Combined Optical Genome Mapping and Comprehensive Genomic Sequencing in Robust Evaluation of Hematological Cancers
Dr. Rashmi Kanagal Shamana MD Anderson Cancer Center Texas, USA A Comprehensive Assessment of a Large MDS Cohort at MD Anderson Cancer Center Using Optical Genome Mapping and a Targeted NGS Panel

 

Symposium registration is open to all and there is no charge for attending this event. Register today!

Top

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.